Browse the evidence

In nonagenarians (≥90 years), declining health (higher frailty index) is associated with an elevation in resting metabolic rate (RMR), which may be driven by decreased muscle mass in women and decreased muscle function (damage) in men.

For those in their 90s, maintaining muscle function is critical not just for movement, but for metabolic health. The study suggests that as health declines, the body burns more energy at rest to maintain itself, potentially draining reserves needed for daily activity. For men, this is linked to muscle damage (enzyme levels); for women, to muscle mass. Preserving muscle quality and quantity may help manage this increased metabolic burden.

Elevated cholesteryl ester transfer protein (CETP) activity is significantly higher in South Asians compared to Europeans and drives the characteristic atherogenic dyslipidemia (high triglycerides, high LDL particle number, low HDL-C) observed in this population.

For South Asian individuals, standard cholesterol tests (LDL-C) may underestimate cardiovascular risk. It is critical to assess lipoprotein particle numbers (via NMR or ApoB) and CETP activity if available, as elevated CETP drives the formation of small, dense LDL particles and low HDL, which are strong predictors of heart disease in this population.

Short-term (7-day) supplementation with cocoa polyphenols (~240 mg/day) does not reduce platelet activation or aggregation in response to acute exercise in either trained or sedentary men.

Taking cocoa polyphenol supplements for one week will not protect your platelets from the stress of a sudden intense workout. If you are sedentary, do not rely on supplements to make strenuous exercise safe; focus on building fitness gradually.

Performing general, specific, or combined warm-ups does not improve repetition performance or reduce fatigue during submaximal (80% 1RM) resistance training sets performed to failure.

If you are training with weights at 80% of your max for multiple sets to failure, skipping the warm-up saves time without costing you reps. Warm-ups are still useful for maximal strength lifts (1RM) or injury prevention, but for hypertrophy-focused fatiguing sets, they offer no performance advantage for detrained individuals.

A 6-month produce prescription program providing $60/month in vouchers for fruit and vegetables does not significantly improve glycemic control (HbA1c), blood pressure, or BMI in patients with diabetes compared to usual care.

For patients with diabetes, simply receiving vouchers for fruit and vegetables is not enough to lower blood sugar. To see health benefits, programs must ensure the voucher amount is sufficient for the patient's household size and include robust, ongoing nutritional education. Without these supports, financial incentives alone may fail to improve clinical outcomes.

Standard diagnostic biomarkers (BNP/NT-proBNP) are less reliable in obese patients with HF due to lower circulating levels caused by increased clearance by adipose tissue, requiring lower cut-off values for diagnosis.

If you are obese and have heart failure symptoms, standard blood tests for heart failure (BNP/NT-proBNP) might show lower levels than expected, even if you have the condition. Doctors should use lower thresholds to diagnose you. Do not assume a 'normal' result means you don't have heart failure if you have symptoms.

Novel antidiabetic agents, specifically SGLT-2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists, exert significant anti-inflammatory effects in the cardiovascular and renal systems, contributing to improved cardiorenal outcomes in type 2 diabetes.

If you have Type 2 Diabetes, ask your doctor about newer medications like SGLT-2 inhibitors or GLP-1 agonists. These drugs do more than just lower blood sugar; they actively reduce inflammation in your blood vessels and kidneys, which helps prevent heart attacks, strokes, and kidney failure. This benefit is independent of how well they control your glucose levels.

GLP-1 receptor agonists reduce cardiovascular inflammation by activating AMPK and CAMKKβ signaling pathways, leading to the downregulation of pro-inflammatory genes and increased SIRT6 expression.

This technical mechanism explains why GLP-1 drugs protect blood vessels. By activating specific cellular 'switches' (AMPK and SIRT6), these drugs turn off inflammatory genes in the vessel walls, preventing plaque buildup and stiffness.

DPP-4 inhibitors reduce systemic inflammation by suppressing the secretion of IL-6 and IL-1β and inhibiting NF-κB nuclear translocation, leading to improved endothelial function and plaque stabilization.

DPP-4 inhibitors (like sitagliptin) help stabilize heart disease plaques by reducing the inflammatory signals (IL-6, IL-1β) that attract immune cells to artery walls. This reduces the risk of plaque rupture and heart attacks.

The 'Dual Intervention Point' (DIP) model proposes that physiological regulation is weak within a 'zone of indifference' (dynamic equilibrium) but becomes strong only when fatness crosses upper or lower intervention points.

Your body's regulatory 'alarm bells' (hunger/satiety signals) may be quiet when you are within a normal weight range (zone of indifference). Strong physiological corrections only happen when you move significantly outside this range (crossing intervention points).

The evolution of human fat storage levels is driven by a trade-off between starvation risk and predation risk, resulting in an optimum fatness that minimizes total mortality, not maximum fat storage.

Your body stores fat to balance survival needs (starvation) against survival costs (predation/mobility). This explains why we don't store maximum possible fat; there is an evolutionary optimum.

Pima Indian males exhibit significantly lower beta-adrenergic sensitivity (higher chronotropic dose-25) compared to Caucasian males, independent of body fat levels.

This research highlights that Pima Indian men may have a biological baseline of lower heart rate responsiveness to beta-adrenergic stimulation compared to Caucasian men, regardless of weight. This is a physiological trait, not a lifestyle failure. It may contribute to lower hypertension rates but higher obesity prevalence in this population. Focus on overall health metrics rather than trying to force a 'Caucasian' physiological response.

In males, increased adiposity is associated with decreased beta-adrenergic sensitivity, whereas this correlation is absent in females.

For men, carrying more body fat tends to blunt the heart's responsiveness to adrenaline-like signals. This link is not seen in women in this study. This suggests that weight management strategies might need to consider sex-specific physiological responses to adiposity.

An intensive lifestyle intervention (ILI) may exacerbate the severity of self-reported problem-solving complaints in Type 2 Diabetes patients who have pre-existing cognitive complaints and a history of cardiovascular disease.

If you have Type 2 Diabetes, existing cognitive complaints, and a history of heart disease, be aware that aggressive lifestyle interventions might be associated with increased reports of problem-solving difficulties. Discuss this specific risk with your doctor to determine if a modified or less intensive approach is safer for your cognitive health.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with a 19% increased risk of incident atrial fibrillation (AF), with risk escalating as liver disease severity (fibrosis/MASH) increases.

If you have MASLD, you have a significantly higher risk of developing atrial fibrillation, even in early stages. Managing metabolic risk factors (weight, blood sugar, blood pressure) is not just about liver health but is a critical strategy for preventing heart rhythm disorders. Early detection and comprehensive management of MASLD are crucial to mitigate this dual burden.

Obesity and Obstructive Sleep Apnea (OSA) exacerbate the risk of AF in MASLD through hemodynamic changes, epicardial fat deposition, and sympathetic nervous system activation.

For MASLD patients, managing weight and treating sleep apnea are critical for preventing AF. These conditions add mechanical and inflammatory stress to the heart, which can be mitigated through lifestyle and medical interventions.

Standardized ex vivo high-resolution respirometry (HRR) measurements of mitochondrial function in permeabilized human skeletal muscle significantly underestimate in vivo metabolic rates because they are conducted at 37°C, whereas mitochondria operate at temperatures up to 10°C higher (approx. 50°C) during maximal exercise.

If you are interpreting mitochondrial function from lab tests on muscle biopsies (ex vivo), be aware that standard tests at 37°C likely underestimate true in vivo capacity. The paper suggests that mitochondrial temperature during exercise can reach ~50°C. To compare lab results with real-world metabolic performance, apply a temperature correction factor (approx. 10°C increase) to the ex vivo data.

Long-term follow-up (median 14 years) of an intensive lifestyle intervention (ILI) targeting weight loss and physical activity in adults with type 2 diabetes and obesity does not significantly reduce the prevalence of frailty compared to diabetes support and education (DSE).

For older adults with diabetes, intensive lifestyle interventions (diet and exercise) provide short-to-medium term benefits in physical function, but these benefits may not persist enough to prevent the clinical syndrome of frailty 14 years later. Sustainable, long-term maintenance of lifestyle changes is critical, as the benefits of intensive programs tend to fade after structured support ends.

Basal glucose homeostasis is governed by insulin-independent mechanisms primarily regulated by the brain, whereas glucose tolerance is determined by the interaction between insulin secretion and insulin sensitivity.

Understanding that fasting blood sugar (basal state) and how your body handles meals (glucose tolerance) are controlled by different systems can explain why some treatments work for one but not the other. Fasting glucose is largely managed by brain-mediated, insulin-independent processes, while meal response relies on insulin. This suggests that therapies targeting the brain (like certain GLP-1 agonists) may help basal glucose even if they don't fully restore insulin sensitivity.

Aging is associated with impaired glucose tolerance due to reduced insulin sensitivity and failure of insulin secretion to compensate, without changes in basal glucose or insulin-independent glucose disposal.

As you age, your body's ability to handle sugar after meals (glucose tolerance) declines due to insulin resistance and insufficient insulin response, but your fasting blood sugar may remain normal. This highlights the importance of monitoring post-meal glucose in older adults.

Whey protein supplementation does not improve bone health biomarkers (formation, resorption, or turnover ratio) in male soldiers undergoing intense initial entry training compared to carbohydrate supplementation.

If you are undergoing intense military or athletic training, drinking whey protein shakes daily will not protect your bones from stress injuries any more than drinking a carbohydrate shake will. Focus on adequate total calorie intake, vitamin D exposure, and managing training load instead of relying on protein supplements for bone health.

The long-term mental health and quality of life benefits of an intensive lifestyle intervention (ILI) for type 2 diabetes do not persist after the intervention is terminated; participants revert to baseline risk levels comparable to a control group.

If you stop the structured support of a lifestyle program, your mental health and quality of life benefits will likely erate over time, even if you maintain some weight loss. To keep the psychological benefits, you need a long-term maintenance plan, not just an initial intensive phase.

Bariatric surgery, by inducing significant weight loss and improving metabolic profiles, reduces the overall incidence of cancer, including esophageal adenocarcinoma.

For individuals with severe obesity, bariatric surgery can significantly reduce the risk of various cancers, including esophageal adenocarcinoma, by promoting sustained weight loss and improving metabolic health.

Smoking is a significant risk factor that increases the risk of incident symptomatic peripheral arterial disease in individuals with diabetes mellitus.

If you smoke, quitting is critical for preventing peripheral arterial disease, especially if you have diabetes. This study shows that smokers have nearly twice the risk of developing PAD compared to non-smokers. Stopping smoking is the most impactful lifestyle change you can make to protect your circulation.